Abstract
A tk− cell line derived from mouse mastocytoma P815 was transfected with a plasmid carrying a thymidine kinase gene. The tk+ cells were obtained at a frequency of 10−6. From some of these tk+ transfectants it was possible to select tk− cells with BrdU so that these cells could be submitted again to transfection with the thymidine kinase gene. By repeating cycles of transfection and tk+ selection followed by reverse selection with BrdU, it was possible to obtain a stable variant having a 100-fold increase in transfection efficiency. This HTR (high transfection) variant shows a high efficiency of transfection (10−4) for the neomycin-resistance gene as well as for the thymidine kinase gene.
Similar content being viewed by others
Literature cited
Lowy, I., Pellicer, A., Jackson, J.F., Sim, G.K., Silverstein, S., and Axel, R. (1980).Cell 22:817–823.
Perucho, M., Hanahan, D., Lipsich, L., and Wigler, M. (1980).Nature 285:207–210.
Bradshaw, H.D. (1983).Proc. Natl. Acad. Sci. U.S.A. 80:5588–5591.
Margulies, D.H., Evans, G.A., Ozato, K., Camerini-Otero, R.D., Tanaka, K., Appella, E., and Seidman, J.G. (1983).J. Immunol. 130:463–470.
Kuhn, L.C., McClelland, A., and Ruddle, F.H. (1984).Cell 37:95–103.
Shih, C., Padhy, L.C., Murray, M., and Weinberg, R.A. (1981).Nature 290:261–264.
Goodenow, R.S., Stroynowski, I., McMillan, M., Nicolson, M., Eakle, K., Taylor Sher, B., Davidson, N., and Hood, L. (1983).Nature 301:388–394.
Graham, F.L., and van der Eb, A.J. (1973).Virology 52:456–467.
Weinberg, R.A. (1981).Biochim. Biophys. Acta 651:25–35.
Southern, P.J., and Berg, P. (1982).J. Mol. Appl. Genet. 1:327–341.
Wigler, M., Sweet, R., Sim, G.K., Wold, B., Pellicer, A., Lacy, E., Maniatis, T., Silverstein, S., and Axel, R. (1979).Cell 16:777–785.
Kavathas, P., and Herzenberg, L.A. (1983).Proc. Natl. Acad. Sci. U.S.A. 80:524–528.
Kuhn, L.C., Barbosa, J.A., Kamarck, M.E., and Ruddle, F.H. (1983).Mol. Biol. Med. 1:335–352.
Neuberger, M.S. (1983).EMBO J. 2:1373–1378.
Gillies, S., Morrison, S., Oi, V., and Tonegawa, S. (1983).Cell 33:717–728.
Ott, M.-O., Sperling, L., Herbomel, P., Yaniv, M., and Weiss, M.C. (1984).EMBO J. 3:2505–2510.
Uyttenhove, C., Van Snick, J., and Boon, T. (1980).J. Exp. Med. 152:1175–1183.
Maryanski, J.L., Szpirer, J., Szpirer, C., and Boon, T. (1983).Somat. Cell Genet. 9:345–357.
Corsaro, C., and Pearson, M.L. (1981).Somat. Cell Genet. 7:603–616.
Ozato, K., Hansen, T.H., and Sachs, D.H. (1980).J. Immunol. 125:2473–2477.
Tonkonogy, S.L., and Amos, D.B. (1981).Immuno-genetics 14:497–505.
Maryanski, J.L., Van Snick, J., Cerottini, J.-C., and Boon, T. (1982).Eur. J. Immunol. 12:401–406.
Uyttenhove, C., Maryanski, J.L., and Boon, T. (1983).J. Exp. Med. 157:1040–1052.
Colbere-Garapin, F., Chousterman, S., Horodniceanu, F., Kourilsky, P., and Garapin, A.C. (1979).Proc. Natl. Acad. Sci. U.S.A. 76:3755–3759.
Nicolas, J.F., and Berg, P. (1983). Teratocarcinoma stem cells. Cold Spring Harbor Conferences on Cell Proliferation, Vol. 10, pp. 469–485.
Davis, R.W., Botstein, D., and Roth, J.R. (1980). InA Manual for Genetic Engineering. (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York), pp. 116–119.
Gross-Bellard, M., Oudet, P., and Chambon, P. (1973).Eur. J. Biochem. 36:32–38.
Heidmann, O., and Rougeon, F. (1982).Cell 28:507–513.
Wigler, M., Pellicer, A., Silverstein, S., and Axel, R. (1978).Cell 14:725–731.
Perucho, M., Hanahan, D., and Wigler, M. (1980).Cell 22:309–317.
Pellicer, A., Robins, D., Wold, B., Sweet, R., Jackson, J., Lowy, I., Roberts, J.M., Sim, G.K., Silverstein, S., and Axel, R. (1980).Science 209:1414–1422.
Clough, D.W., Kunkel, L.M., and Davidson, R.L. (1982).Science 216:70–73.
Ostrander, M., Vogel, S., and Silverstein, S. (1982).Mol. Cell. Biol. 2:708–714.
Christy, B.A., and Scangos, G.A. (1984).Mol. Cell. Biol. 4:611–617.
Davies, R.L., Fuhrer-Krusi, S., and Kucherlapati, R.S. (1982).Cell 31:521–529.
Kaufman, E.R., and Davidson, R.L. (1978).Proc. Natl. Acad. Sci. U.S.A. 75:4982–4986.
Boon, T. (1983).Adv. Cancer Res. 39:121–151.
Bernarbeu, C., Finlay, D., van de Rijn, M., Maziarz, R., Biro, A., Spits, H., de Vries, J. and Terhorst, C. (1983).J. Immunol. 131:2032–2037.
Maryanski, Y.L., Moretta, A., Jordan, B., De Plaen, E., Van Pel, A., Boon, T. and Cerottini, Y-C. (1985)Eur. Y. Immunol., in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Pel, A., De Plaen, E. & Boon, T. Selection of highly transfectable variant from mouse mastocytoma P815. Somat Cell Mol Genet 11, 467–475 (1985). https://doi.org/10.1007/BF01534840
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01534840